Sign in
CompletedNo phase

A Food Additive Removal Diet for Pediatric Eosinophilic Esophagitis

Key facts

Who runs it
Nemours Children's Clinic
Where
Orlando, Seattle, and Wilmington, United StatesSee the 3 sites
Trial code
Status
Completed
People taking part
22 people enrolled
Started
12 Nov 2018
Ended
31 Dec 2023
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • DED
  • FREE
Record updated
10 February 2025

Who can take part

Age
2 years to 18 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 18 criteriaShow less

Who can take part

  • An Institutional Review Board (IRB) approved written Parental Permission form is signed and dated by the parent or legal representative/caregiver
  • If applicable, an Institutional Review Board (IRB) approved written Assent form is signed and dated by the participant
  • The participant/parent(s) or legal representative(s)/caregiver(s) are considered reliable and capable of adhering to the protocol call schedule and dietary requirements
  • The participant is >2 years to <18 years of age
  • The participant has isolated esophageal eosinophilia (>15 eos/hpf)
  • The family has access to the internet to complete weekly surveys and to a telephone to complete weekly follow up calls
  • The biopsy used to diagnose eosinophilic esophagitis was taken no more than 12 weeks prior to the date of enrollment

Who cannot take part

  • The participant has concomitant GI inflammatory conditions (e.g. celiac disease, inflammatory bowel disease)
  • The participant is currently taking a PPI (If discontinued, no washout required.)
  • The participant is currently on or previously failed a dairy free diet for EoE
  • The participant has a history of upper GI tract surgery (e.g. fundoplication)
  • The participant has other significant medical conditions that, in the opinion of the provider, would impact the participant's ability to participate in the study
  • The participant has a psychiatric condition that, in the opinion of the investigator, could jeopardize the participant's ability to participate in the study
  • The participant has peripheral eosinophilia > 1,500 µL
  • Acid reflux by pH probe is suggested (*A pH probe is not required, but may be done as standard of care)
  • The participant has severe developmental delay that, in the opinion of the investigator, could jeopardize the participant's ability to participate in the study
  • The participant has taken prednisone in the last 12 weeks, or has taken fluticasone or budesonide in the last 8 weeks
  • The participant does not speak or read English fluently

Where in United States

  • Nemours Children's HospitalOrlando, United States
  • Seattle Children's HospitalSeattle, United States
  • Nemours/Alfred I. duPont Hospital for ChildrenWilmington, United States

About the trial

What the trial wants to find out

Prospective, pragmatic standard of care clinical trial comparing dietary therapies of standard dairy elimination diet alone (DED) to dairy elimination plus food additive elimination (FREE)

The 2 groups in the trial

  • DEDExisting treatment, for comparison

    Diet eliminating dairy

  • FREEExisting treatment, for comparison

    Diet eliminating dairy and food additives

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Record updated
10 February 2025